Alphatec Holdings, Inc.
$11.55
▼
-3.82%
2026-04-21 05:26:01
www.atecspine.com
NMS: ATEC
Explore Alphatec Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.68 B
Current Price
$11.55
52W High / Low
$23.29 / $9.89
Stock P/E
—
Book Value
$0.08
Dividend Yield
—
ROCE
-10.13%
ROE
-6.31%
Face Value
—
EPS
$-0.96
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
913
Beta
1.12
Debt / Equity
1,654.48
Current Ratio
2.06
Quick Ratio
1.28
Forward P/E
19.8
Price / Sales
2.16
Enterprise Value
$2.11 B
EV / EBITDA
107.99
EV / Revenue
2.76
Rating
Strong Buy
Target Price
$24.42
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
Cons
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Quantum-Si incorporated | $1.01 | — | $231.51 M | — | -43.74% | -46.52% | $3.1 / $0.69 | $1.02 |
| 2. | Xtant Medical Holdings, Inc. | $0.5 | 15.1 | $75.1 M | — | 11.26% | 10.59% | $0.95 / $0.39 | $0.36 |
| 3. | Apyx Medical Corporation | $3.94 | — | $166.48 M | — | -11.69% | -76.15% | $4.5 / $0.83 | $0.35 |
| 4. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
| 5. | Pacific Biosciences of California, Inc. | $1.74 | — | $510.38 M | — | -78.39% | -2.13% | $2.73 / $0.85 | $0.02 |
| 6. | Modular Medical, Inc. | $5.41 | — | $27.31 M | — | -109.03% | -3.32% | $34.5 / $3.55 | $2.27 |
| 7. | Quanterix Corporation | $3.3 | — | $164.29 M | — | -31.92% | -34.25% | $8.77 / $3.23 | $6.33 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 212.93 M | 196.5 M | 185.54 M | 169.18 M | 176.79 M |
| Operating Profit | -5.36 M | -9.41 M | -11.48 M | -31.71 M | -20.92 M |
| Net Profit | -21.73 M | -28.58 M | -41.14 M | -51.91 M | -33.33 M |
| EPS in Rs | -0.14 | -0.19 | -0.27 | -0.34 | -0.22 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 764.15 M | 611.56 M | 482.26 M | 350.87 M |
| Operating Profit | -57.97 M | -122.91 M | -148.28 M | -121.1 M |
| Net Profit | -143.36 M | -162.12 M | -186.64 M | -151.29 M |
| EPS in Rs | -0.95 | -1.07 | -1.23 | -1 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 791.21 M | 775.71 M | 805.21 M | 520.97 M |
| Total Liabilities | 778.78 M | 789.88 M | 727.09 M | 555.63 M |
| Equity | 12.43 M | -14.17 M | 78.12 M | -34.67 M |
| Current Assets | 450.88 M | 417.4 M | 451.09 M | 255.63 M |
| Current Liabilities | 219.18 M | 153.03 M | 157.57 M | 138.87 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 45.23 M | -44.65 M | -78.48 M | -75.13 M |
| Investing CF | -53.41 M | -93.14 M | -141.97 M | -58.28 M |
| Financing CF | 30.02 M | 56.21 M | 356.92 M | 31.23 M |
| Free CF | -4.41 M | -137.79 M | -165.46 M | -133.41 M |
| Capex | -49.64 M | -93.14 M | -86.97 M | -58.28 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 24.95% | 26.81% | 37.45% | — |
| Earnings Growth % | 11.57% | 13.14% | -23.36% | — |
| Profit Margin % | -18.76% | -26.51% | -38.7% | -43.12% |
| Operating Margin % | -7.59% | -20.1% | -30.75% | -34.52% |
| Gross Margin % | 69.6% | 69.37% | 64.32% | 66.42% |
| EBITDA Margin % | -1.95% | -8.81% | -22.93% | -29.24% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.